A TFIID-SAGA Perturbation that Targets MYB and Suppresses Acute Myeloid Leukemia
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Summary Targeting of general coactivators is an emerging strategy to interfere with oncogenic transcription factors (TFs). However, coactivator perturbations are often pleiotropic and influence numerous TFs. Here we identify TAF12, a subunit of TFIID-SAGA coactivator complexes, as a selective requirement for acute myeloid leukemia (AML) progression. We trace this dependency to a direct interaction between the TAF12/TAF4 histone-fold heterodimer and the transactivation domain of MYB, a TF with established roles in leukemogenesis. Ectopic expression of the TAF4 histone-fold fragment can efficiently squelch TAF12 in cells, suppress MYB, and regress AML in mice. Our study reveals a strategy for potent MYB inhibition in AML and highlights how an oncogenic TF can be selectively neutralized by targeting a general coactivator complex.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
GREAT improves functional interpretation of cis-regulatory regions
McLean, C. Y., Bristor, D., Hiller, M., Clarke, S. L., Schaar, B. T., Lowe, C. B., Wenger, A. M., & Bejerano, G. (2010) · Nature Biotechnology · doi:10.1038/nbt.1630 · Cited by 4,502
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
Zuber, J., Shi, J., Wang, E., Rappaport, A. R., Herrmann, H., Sison, E. A., Magoon, D., Qi, J., Blatt, K., Wunderlich, M., et al. (2011) · Nature · doi:10.1038/nature10334 · Cited by 1,870 · cited 3×
“BRD4 can be released from TF binding sites in the genome by small-molecule inhibitors (e.g., JQ1 and I-BET), which leads to suppression of TF output to induce a powerful anti-leukemia response (Bhagwat et al., 2016; Dawson et al., 2011; Roe et al., 2015; Zuber et al., 2011b).”
BackgroundSelf-citationRetinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
Lo-Coco, F., Avvisati, G., Vignetti, M., Thiede, C., Orlando, S. M., Iacobelli, S., Ferrara, F., Fazi, P., Cicconi, L., Di Bona, E., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1300874 · Cited by 1,611 · cited 1×
“Direct targeting of PML-RARA with all-trans retinoic acid and arsenic trioxide is curative in the subset of AML patients harboring this genetic alteration (Lo-Coco et al., 2013).”
BackgroundTzelepis, K., Koike-Yusa, H., De Braekeleer, E., Li, Y., Metzakopian, E., Dovey, O. M., Mupo, A., Grinkevich, V., Li, M., Mazan, M., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.079 · Cited by 761 · cited 1×
“Cancer Cell 33, 13–28, January 8, 2018 25 SAGA contains both lysine acetyltransferase and ubiquitin protease activities, which could be targetable with small molecules (Tzelepis et al., 2016; Weake and Workman, 2012).”
BackgroundRole of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation
Shi, J., Whyte, W. A., Zepeda-Mendoza, C. J., Milazzo, J. P., Shen, C., Roe, J.-S., Minder, J. L., Mercan, F., Wang, E., Eckersley-Maslin, M. A., et al. (2013) · Genes & Development · doi:10.1101/gad.232710.113 · Cited by 463
Self-citationA Rapid and Scalable System for Studying Gene Function in Mice Using Conditional RNA Interference
Premsrirut, P. K., Dow, L. E., Kim, S. Y., Camiolo, M., Malone, C. D., Miething, C., Scuoppo, C., Zuber, J., Dickins, R. A., Kogan, S. C., et al. (2011) · Cell · doi:10.1016/j.cell.2011.03.012 · Cited by 315
Carpinelli, M. R., Hilton, D. J., Metcalf, D., Antonchuk, J. L., Hyland, C. D., Mifsud, S. L., Di Rago, L., Hilton, A. A., Willson, T. A., Roberts, A. W., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401496101 · Cited by 179 · cited 2×
“…is some phenotypic heterogeneity among different alleles, mice with hypomorphic mutations of MYB are viable, with intact myelopoiesis, enhanced HSC self-renewal, and impaired B and T lymphopoiesis (Carpinelli et al., 2004; Emambokus et al., 2003; Papathanasiou et al., 2010; Sandberg et al., 2005).”
Control of embryonic stem cell lineage commitment by core promoter factor, TAF3
Liu, Z., Scannell, D. R., Eisen, M. B., & Tjian, R. (2011) · Cell · doi:10.1016/j.cell.2011.08.005 · Cited by 167
Wang, E., Kawaoka, S., Roe, J.-S., Shi, J., Hohmann, A. F., Xu, Y., Bhagwat, A. S., Suzuki, Y., Kinney, J. B., & Vakoc, C. R. (2015) · eLife · doi:10.7554/elife.06377 · Cited by 54 · cited 4×
“This system enables shRNA-mediated knockdown in a broad array of normal adult tissues (Bolden et al., 2014; Premsrirut et al., 2011; Wang et al., 2015).”
BackgroundInfluentialSelf-citation
Cited by
TP63-mediated enhancer reprogramming drives the squamous subtype of pancreatic ductal adenocarcinoma
Somerville, T. D. D., Xu, Y., Miyabayashi, K., Tiriac, H., Cleary, C. R., Maia-Silva, D., Milazzo, J. P., Tuveson, D. A., & Vakoc, C. R. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.10.051 · Cited by 225
Self-citationLoss of Kat2a enhances transcriptional noise and depletes acute myeloid leukemia stem-like cells
Domingues, A. F., Kulkarni, R., Giotopoulos, G., Gupta, S., Vinnenberg, L., Arede, L., Foerner, E., Khalili, M., Adao, R. R., Johns, A., et al. (2020) · eLife · doi:10.7554/elife.51754 · Cited by 52
Bell, C. C., Balic, J. J., Talarmain, L., Gillespie, A., Scolamiero, L., Lam, E. Y. N., Ang, C.-S., Faulkner, G. J., Gilan, O., & Dawson, M. A. (2024) · Nature Genetics · doi:10.1038/s41588-024-01749-z · Cited by 30
Rapid interrogation of cancer cell of origin through CRISPR editing
Feng, W., Cao, Z., Lim, P. X., Zhao, H., Luo, H., Mao, N., Lee, Y. S., Rivera, A. A., Choi, D., Wu, C., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2110344118 · Cited by 25
“For orthotopic transplantation of organoid cells, cells were transduced with Lenti-luciferase-P2A-Neo (Addgene plasmid #105621) (45) and selected with 500 μg/mL G418.”
MethodTAF2 condensation in nuclear speckles links basal transcription factor TFIID to RNA splicing factors
Bhuiyan, T., Arecco, N., Mendoza Sanchez, P. K., Kim, J., Schwan, C., Weyrauch, S., Nizamuddin, S., Prunotto, A., Tekman, M., Biniossek, M. L., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115616 · Cited by 5
Metadata
- Authors
- Xu, Y., Milazzo, J. P., Somerville, T. D. D., Tarumoto, Y., Huang, Y.-H., Ostrander, E. L., Wilkinson, J. E., Challen, G. A., & Vakoc, C. R.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2018-01
- Volume
- 33
- Issue
- 1
- Pages
- 13-28.e8
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2783740967
- Cited by
- 74
- References
- 10
- FWCI
- 5.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A TFIID-SAGA Perturbation that Targets MYB and Suppresses Acute Myeloid Leukemia. https://app.cochat.ai/papers/10.1016/j.ccell.2017.12.002
- The paper
- Xu, Y., Milazzo, J. P., Somerville, T. D. D., Tarumoto, Y., Huang, Y.-H., Ostrander, E. L., Wilkinson, J. E., Challen, G. A., & Vakoc, C. R. (2018). A TFIID-SAGA Perturbation that Targets MYB and Suppresses Acute Myeloid Leukemia. Cancer Cell. https://doi.org/10.1016/j.ccell.2017.12.002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.